Skip to main content

Percutaneous Transvenous Mitral Commissurotomy (PTMC) - Opening Hearts, Restoring Hope

 


Healing Hearts, Restoring Rhythm: A Step-by-Step Guide to Percutaneous Transvenous Mitral Commissurotomy (PTMC)


Keywords: PTMC, mitral stenosis, heart valve disease, minimally invasive procedure, interventional cardiology

Introduction:

Mitral stenosis, a narrowing of the mitral valve opening, affects millions worldwide, causing symptoms like shortness of breath, fatigue, and palpitations. Percutaneous Transvenous Mitral Commissurotomy (PTMC) is a minimally invasive procedure that offers a life-changing solution for these patients. In this article, we'll delve into the world of PTMC, explaining the step-by-step process and shedding light on this remarkable treatment option.

What is PTMC?

PTMC is a non-surgical procedure used to treat mitral stenosis. It involves using a balloon catheter to widen the narrowed mitral valve, restoring normal blood flow and alleviating symptoms.

Step-by-Step Guide to PTMC:

Step 1: Preparation

Patients undergo thorough evaluation, including echocardiography, ECG, and blood tests.
Fasting and medication instructions are provided.
Informed consent is obtained.

Step 2: Access and Catheterization

Local anesthesia is administered, and a small incision is made in the femoral vein (groin area).
A guidewire and introducer sheath are inserted, followed by a balloon catheter.
The catheter is advanced through the vein, guided by fluoroscopy and echocardiography.

Step 3: Crossing the Mitral Valve

The balloon catheter is carefully maneuvered across the mitral valve.
A specialized catheter, called a "Brockenbrough needle," may be used to help cross the valve.

Step 4: Balloon Inflation

The balloon catheter is inflated with a contrast agent, allowing visualization of the valve.
The balloon is gradually inflated to widen the valve opening.

Step 5: Commissurotomy

The inflated balloon is used to split the fused commissures (valve leaflets).
The valve opening is enlarged, restoring normal blood flow.

Step 6: Balloon Deflation and Removal

The balloon is deflated, and the catheter is removed.
The introducer sheath is also removed, and the incision site is closed.

Step 7: Post-Procedure Care

Patients are monitored for several hours to ensure stability.
Echocardiography and ECG are performed to assess the procedure's success.
Patients are advised to rest and avoid heavy lifting or strenuous activities.

Benefits and Risks:

PTMC offers numerous benefits, including:

Minimally invasive, reducing recovery time and scarring
High success rate in improving symptoms and valve function
Low risk of complications compared to surgical alternatives

However, as with any medical procedure, risks and potential complications exist:

Bleeding or hematoma at the access site
Infection or sepsis
Valve damage or regurgitation
Stroke or transient ischemic attack

Conclusion:

Percutaneous Transvenous Mitral Commissurotomy (PTMC) is a remarkable treatment option for patients with mitral stenosis. By understanding the step-by-step process and benefits of PTMC, patients and healthcare professionals can make informed decisions about this life-changing procedure. If you or someone you know is living with mitral stenosis, consult with a healthcare professional to discuss the potential of PTMC in restoring heart rhythm and improving quality of life.


Comments

Popular posts from this blog

STEMI ECG Criteria and Universal Definition of MI

  STEMI ECG Criteria and the Universal Definition of Myocardial Infarction: A Complete Guide for Clinicians Early and accurate diagnosis of acute myocardial infarction (AMI) remains the cornerstone of reducing morbidity and mortality in patients presenting with chest pain. Among all forms of acute coronary syndromes (ACS), ST-elevation myocardial infarction (STEMI) represents the most time-sensitive emergency, requiring immediate reperfusion therapy. This article provides a clinically relevant summary of the STEMI ECG criteria and the Universal Definition of Myocardial Infarction (UDMI), based on the latest consensus guidelines from the ESC, ACC, AHA, and WHF. --- 1. Understanding STEMI: Why Accurate ECG Interpretation Matters A 12-lead ECG remains the first and most critical diagnostic test when evaluating suspected myocardial infarction. STEMI is identified when there is evidence of acute coronary artery occlusion, producing transmural ischemia and characteristic ST-segment eleva...

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.